John Maraganore, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 15,075 shares at $68.24 ($1.0M) on 2016-04-20, disclosed to the SEC on 2016-04-21.
Open-market sale of $1.0M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.38 | 12,670 | $854K | 83.9% |
| 2 | $68.24 | 2,405 | $164K | 16.1% |
| Total | $67.52 avg | 15,075 | $1.0M | 100% |
| Filing → |
| ALNY | SELL | 2021-05-17 | $8.9M | — | Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |